|
|
See Category: Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
ICD-10 (CM) Code and Descriptor
|
R83.5 |
Abnormal microbiological findings in cerebrospinal fluid
|
R835 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 9 |
ICD10
Position 10 |
ICD10
Position 14 |
| 26.37%
|
15.38%
|
14.29%
|
5.49%
|
9.89%
|
5.49%
|
4.40%
|
1.10%
|
15.38%
|
1.10%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for R83.5*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
7
|
7
|
|
80053
|
COMPREHEN METABOLIC PANEL |
3
|
3
|
|
87040
|
BLOOD CULTURE FOR BACTERIA |
2
|
2
|
|
83970
|
ASSAY OF PARATHORMONE |
2
|
2
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
2
|
2
|
|
86618
|
LYME DISEASE ANTIBODY |
2
|
2
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
2
|
2
|
|
86611
|
BARTONELLA ANTIBODY |
2
|
4
|
|
82105
|
ALPHA-FETOPROTEIN SERUM |
1
|
1
|
|
82378
|
CARCINOEMBRYONIC ANTIGEN |
1
|
1
|
|
85610
|
PROTHROMBIN TIME |
1
|
1
|
|
86304
|
IMMUNOASSAY TUMOR CA 125 |
1
|
1
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
1
|
1
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
1
|
100
|
|
86617
|
LYME DISEASE ANTIBODY |
1
|
2
|
|
82330
|
ASSAY OF CALCIUM |
1
|
1
|
|
83615
|
LACTATE (LD) (LDH) ENZYME |
1
|
1
|
|
83735
|
ASSAY OF MAGNESIUM |
1
|
1
|
|
84100
|
ASSAY OF PHOSPHORUS |
1
|
1
|
|
84550
|
ASSAY OF BLOOD/URIC ACID |
1
|
1
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
R83.5 related to the following DRG Codes:
091-093
|
